Find Lilly Clinical Trials | Learn About Our Research - Lilly Trials
Lilly's new Trial Connect feature allows you to search for clinical trials that may be the best fit for you or a loved one. Simply answer a few questions to find which Lilly trials may be the best …
A Study to Investigate the Effect of Lepodisiran on the Reduction …
The purpose of this study is to evaluate the efficacy of lepodisiran in reducing cardiovascular risk in participants with high lipoprotein(a) who have cardiovascular disease or are at risk of a heart …
Lilly's muvalaplin lowered lipoprotein(a) levels in adults with high ...
INDIANAPOLIS, Nov. 18, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced positive Phase 2 results for muvalaplin, an investigational once-daily, orally …
FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's …
Jan 15, 2025 · This approval is based on positive results from the Phase 3 VIVID-1 study of Omvoh in adults with moderately to severely active Crohn's disease who had an inadequate ...
Lilly's tirzepatide successful in phase 3 study ... - Eli Lilly and …
Aug 1, 2024 · SUMMIT (NCT04847557) was a multi-center, randomized, double-blind, parallel, placebo-controlled phase 3 study comparing the efficacy and safety of tirzepatide to placebo in …
Clinical Development Pipeline | Science | Eli Lilly and Company
Oct 30, 2024 · Learn about Lilly's pipeline, including information about our investigational molecules and potential indication data.
Clinical Trials and Research | Eli Lilly and Company
A clinical trial is a research study that tests a medicine or therapy in people to help us understand how well it works and how safe it is. Clinical trials contribute to the advancement of medicine …
Lilly Obesity and Overweight Clinical Trials | Weight ... - Lilly Trials
Lilly partners with clinical trial volunteers to develop new weight management treatment options. Learn more about obesity research and find Lilly trials here.
With new data, Lilly sets pace for next wave of breast cancer drugs
Dec 11, 2024 · An experimental breast cancer drug developed by Eli Lilly met its main goal in a Phase 3 study, helping people with a form of HER2-negative, ER-positive disease stay alive …
Lilly's obesity drug leads to about 26% weight loss in new studies
Jul 27, 2023 · Eli Lilly said on Thursday its experimental obesity drug helped patients reduce 26.6% of weight, on average, across two late-stage studies after intensive lifestyle changes or …